Rtw Investments as of Dec. 31, 2016
Portfolio Holdings for Rtw Investments
Rtw Investments holds 32 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Avexis | 15.2 | $41M | 849k | 47.73 | |
Bristol Myers Squibb (BMY) | 12.4 | $33M | 566k | 58.44 | |
Alnylam Pharmaceuticals (ALNY) | 11.1 | $30M | 789k | 37.44 | |
BioCryst Pharmaceuticals (BCRX) | 9.7 | $26M | 4.1M | 6.33 | |
La Jolla Pharmaceuticl Com Par | 7.2 | $19M | 1.1M | 17.53 | |
Agenus | 6.5 | $17M | 4.2M | 4.12 | |
Medicines Company | 4.8 | $13M | 374k | 33.94 | |
Ptc Therapeutics I (PTCT) | 4.1 | $11M | 997k | 10.91 | |
Incyte Corporation (INCY) | 3.3 | $8.7M | 87k | 100.27 | |
Oxford Immunotec Global | 3.1 | $8.1M | 543k | 14.95 | |
United States Oil Fund | 3.0 | $7.9M | 675k | 11.72 | |
Bluebird Bio (BLUE) | 2.9 | $7.6M | 123k | 61.70 | |
Dicerna Pharmaceuticals | 2.2 | $5.9M | 2.0M | 2.88 | |
Masimo Corporation (MASI) | 2.0 | $5.5M | 81k | 67.40 | |
Atara Biotherapeutics | 2.0 | $5.3M | 373k | 14.20 | |
Corium Intl | 1.7 | $4.5M | 1.1M | 4.06 | |
Regenxbio Inc equity us cm (RGNX) | 1.7 | $4.4M | 240k | 18.55 | |
Viveve Med | 1.6 | $4.3M | 840k | 5.15 | |
Tactile Systems Technology, In (TCMD) | 1.5 | $4.1M | 249k | 16.41 | |
Invuity | 1.0 | $2.6M | 455k | 5.75 | |
Omeros Corporation (OMER) | 1.0 | $2.6M | 259k | 9.92 | |
Achillion Pharmaceuticals | 0.5 | $1.2M | 286k | 4.13 | |
Celldex Therapeutics | 0.3 | $848k | 240k | 3.54 | |
Sensus Healthcare (SRTS) | 0.2 | $645k | 123k | 5.25 | |
Mirati Therapeutics | 0.2 | $616k | 130k | 4.75 | |
Biopharmx | 0.2 | $471k | 1.3M | 0.37 | |
Global Blood Therapeutics In | 0.1 | $375k | 26k | 14.44 | |
Natera (NTRA) | 0.1 | $371k | 32k | 11.71 | |
Audentes Therapeutics | 0.1 | $365k | 20k | 18.25 | |
MannKind Corporation | 0.1 | $281k | 439k | 0.64 | |
Nivalis Therapeutics | 0.0 | $67k | 30k | 2.23 | |
Sensus Healthcare Inc Wrt Exp | 0.0 | $78k | 155k | 0.50 |